Stay updated on Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial

Sign up to get notified when there's something new on the Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    ClinicalTrials.gov’s page revision/version label was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-26T08:25:14.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-19T01:29:53.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.5.0 is now displayed on the page, replacing Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T02:10:56.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T21:13:14.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision updated to v3.4.2, replacing the previous v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-12T02:25:50.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 with no observable changes to study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:38:30.000Z thumbnail image

Stay in the know with updates to Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial page.